Showing results (711-720 of 9,900) with videos related to
Sort By:
Pageof 990
Bone Marrow Transplantation|August 6, 1999
Psychosocial adjustment of pediatric patients after allogeneic stem cell transplantationR Felder-Puig, C Peters, S Matthes-Martin, et al.Bone Marrow Transplantation|April 10, 1999
Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantationA A Shlebak, S B Marley, I A Roberts, et al.Bone Marrow Transplantation|April 10, 1999
Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot studyA Wiesmann, A Weller, G Lischka, et al.Bone Marrow Transplantation|April 10, 1999
Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled studyS M Kelsey, J M Goldman, S McCann, et al.Bone Marrow Transplantation|March 20, 1999
Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID miceD Bonnet, M Bhatia, J C Wang, et al.Bone Marrow Transplantation|March 20, 1999
Correction of bone marrow failure in dyskeratosis congenita by bone marrow transplantationA Ghavamzadeh, K Alimoghadam, P Nasseri, et al.Bone Marrow Transplantation|April 27, 1999
The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating abilityB Balint, Z Ivanović, M Petakov, et al.Bone Marrow Transplantation|February 26, 1999
Effects of short-term administration of G-CSF (filgrastim) on bone marrow progenitor cells: analysis of serial marrow samples from normal donorsC Martínez, A Urbano-Ispizua, M Rozman, et al.Bone Marrow Transplantation|February 26, 1999
Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantationR Salazar, C Solá, P Maroto, et al.Bone Marrow Transplantation|February 26, 1999
The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantationA Humar, K O'Rourke, J Lipton, et al.Pageof 990